Adnexi

Associate Sponsor

Clinical Trial Enrollment Accelarator - When Every Patient Counts

At Adnexi, we specialize in solving one of biopharma's toughest challenges: enrolling clinical trials in rare and ultra-rare diseases, fully and as fast as possible. Our proprietary platform combines targeted digital recruitment, compliant online and phone prescreening, and intelligent trial site matching to connect eligible patients with trials faster. In one ultra-rare disease Phase 3 program, we drove approximately 30% of total trial randomizations within 12 months. Trusted by leading biopharma companies Adnexi maps KOL, DOL and PAG expert networks and deploys enrollment acceleration campaigns for to reach hard-to-find populations. More at adnexi.com

website